Hemminki E (1980)

Study of information submitted by drug companies to licensing authorities. BMJ 280:833-6.
Using drug research done during the late 1970s, Elina Hemminki, a Finnish health services researcher, showed that studies of new drugs submitted to licensing authorities were less likely to be published subsequently if they had looked for adverse effects.

Key passage(s)


Whole article


Elina Hemminki (1948)


The editors are grateful to:

BMJ for allowing the James Lind Library to link to this and other BMJ articles of historical relevance (email to Iain Chalmers from Fiona Godlee, 05 May 2015).